Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal canc…
$1.94+1.09%
报价 2026-11-13
市值
$2M
EV
$6.2M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -99.2%
$1.64$235.60
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PPCBPropanc Biopharma, Inc. | $2M | +1.1% | – | 0% | – | – | – | |
| JUNSJupiter Neurosciences, Inc. | $2.3M | -5.4% | +12000.0% | 88.3% | – | – | – | |
| CMNDClearmind Medicine Inc. | $2.3M | -1.9% | – | 0% | – | – | – | |
| VIVSVivoSim Labs, Inc. | $2.1M | -7.8% | 0.0% | -134.8% | – | – | – | |
| SILOSilo Pharma, Inc. | $2.1M | -3.7% | 0.0% | -474.3% | – | – | – | |
| BRTXBioRestorative Therapies, Inc. | $2.1M | -0.7% | +180.0% | 92.1% | – | – | – | |
| XRTXXORTX Therapeutics Inc. | $2M | +19.6% | – | 0% | – | – | – | |
| CANFCan-Fite BioPharma Ltd. | $1.9M | -4.7% | – | 100% | – | – | – | |
| SXTP60 Degrees Pharmaceuticals, Inc. | $1.8M | -0.2% | +35.7% | 19.4% | – | – | – | |
| 同行中位数 | – | – | +35.7% | 9.7% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。